☆ 4.7 Editorial Material

Debunking the Delusion That Precision Oncology Is an Illusion

ONCOLOGIST (2017)

Get Full Text
Add to Collection

Journal

ONCOLOGIST
Volume 22, Issue 8, Pages 881-882

Publisher

WILEY
DOI: 10.1634/theoncologist.2017-0040

Keywords

-

Categories

Oncology

Funding

  1. Novartis
  2. Bayer
  3. Roche/Genentech
  4. Nanocarrier
  5. Fujifilm
  6. Incyte
  7. Northwest Biotherapeutics
  8. D3
  9. ABBVIE
  10. Berghealth
  11. Genen-tech
  12. Pfizer
  13. Sequenom
  14. Guardant
  15. Foundation Medicine
  16. Merck Serono

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.